These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18365833)

  • 21. Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity.
    Pai S; Thomas R
    J Autoimmun; 2008 Nov; 31(3):245-51. PubMed ID: 18539434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
    Sarkar FH; Li Y; Wang Z; Kong D
    Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-kappaB in liver diseases: a target for drug therapy.
    Muriel P
    J Appl Toxicol; 2009 Mar; 29(2):91-100. PubMed ID: 18937212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of NF-kappaB activation in intestinal immune homeostasis.
    Wullaert A
    Int J Med Microbiol; 2010 Jan; 300(1):49-56. PubMed ID: 19781989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcription factor cross-talk: the estrogen receptor and NF-kappaB.
    Kalaitzidis D; Gilmore TD
    Trends Endocrinol Metab; 2005 Mar; 16(2):46-52. PubMed ID: 15734144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (-)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB.
    Lin RW; Chen CH; Wang YH; Ho ML; Hung SH; Chen IS; Wang GJ
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1033-7. PubMed ID: 19150340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear factor-kappa B in intestinal protection and destruction.
    Spehlmann ME; Eckmann L
    Curr Opin Gastroenterol; 2009 Mar; 25(2):92-9. PubMed ID: 19528876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteopetroses and immunodeficiencies in humans.
    Villa A; Vezzoni P; Frattini A
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):421-7. PubMed ID: 17088646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RANK/RANKL: regulators of immune responses and bone physiology.
    Leibbrandt A; Penninger JM
    Ann N Y Acad Sci; 2008 Nov; 1143():123-50. PubMed ID: 19076348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ah receptor and NF-kappaB interplay on the stage of epigenome.
    Tian Y
    Biochem Pharmacol; 2009 Feb; 77(4):670-80. PubMed ID: 19014911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of (-)-saucerneol on osteoclast differentiation and bone pit formation.
    Kim SN; Kim MH; Kim YS; Ryu SY; Min YK; Kim SH
    Phytother Res; 2009 Feb; 23(2):185-91. PubMed ID: 18690659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
    Tsuji-Naito K
    Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention.
    Peterson JM; Guttridge DC
    Int Rev Immunol; 2008; 27(5):375-87. PubMed ID: 18853344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
    Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
    Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation.
    Blander JM
    Methods Mol Biol; 2009; 512():99-117. PubMed ID: 19347275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer.
    Horst D; Budczies J; Brabletz T; Kirchner T; Hlubek F
    Cancer; 2009 Nov; 115(21):4946-58. PubMed ID: 19658179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages.
    Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y
    J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear factor-kappaB: fine-tuning a central integrator of diverse biologic stimuli.
    Krakauer T
    Int Rev Immunol; 2008; 27(5):286-92. PubMed ID: 18853340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of ubiquitin in NF-kappaB regulatory pathways.
    Skaug B; Jiang X; Chen ZJ
    Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.